Thyroid Eye Disease
- PMID: 36556449
- PMCID: PMC9787503
- DOI: 10.3390/life12122084
Thyroid Eye Disease
Abstract
Thyroid eye disease (TED), an autoimmune inflammatory disorder of the orbit, presents with a potential array of clinical sequelae. The pathophysiology behind TED has been partially characterized in the literature. There remain certain elusive mechanisms welcoming of research advances. Disease presentation can vary, but those that follow a characteristic course start mild and increase in severity before plateauing into an inactive phase. Diagnosis and evaluation include careful physical examination, targeted laboratory work up, appropriate imaging studies, and tailored treatment regimens. Special consideration may apply to certain populations, such as pediatric and pregnant patients.
Keywords: Grave’s disease; Hashimoto’s thyroiditis; chronic lymphocytic thyroiditis; euthyroid eye disease; exophthalmos; orbital inflammation; proptosis; teprotumumab; thyroid eye disease; thyroid-associated orbitopathy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Stan M.N. Natural History, Risk Factors, and Management of Patients with Mild GO. In: Bahn R.S., editor. Graves’ Disease—A Comprehensive Guide for Clinicians. Springer Science+Business Media; New York, NY, USA: 2015. pp. 241–255.
Publication types
LinkOut - more resources
Full Text Sources
